Elizabeth Hoge - Apr 8, 2024 Form 4 Insider Report for Cartesian Therapeutics, Inc. (RNAC)

Role
10%+ Owner
Signature
/s/ Murat Kalayoglu, Authorized Person
Stock symbol
RNAC
Transactions as of
Apr 8, 2024
Transactions value $
$0
Form type
4
Date filed
4/10/2024, 04:20 PM
Previous filing
Nov 17, 2023
Next filing
Oct 15, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RNAC Common Stock Conversion of derivative security +2.93M +2657.72% 3.04M Apr 8, 2024 as trustee F1, F2
transaction RNAC Common Stock Conversion of derivative security +492K +3386.48% 506K Apr 8, 2024 by spouse F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RNAC Series A Non-Voting Convertible Preferred Stock Conversion of derivative security $0 -87.8K -46.27% $0.00 102K Apr 8, 2024 Common Stock 2.93M by trust F1, F2
transaction RNAC Series A Non-Voting Convertible Preferred Stock Conversion of derivative security $0 -14.8K -100% $0.00* 0 Apr 8, 2024 Common Stock 492K by spouse F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Following the approval by the stockholders of the issuer of the conversion of the Series A Non-Voting Convertible Preferred Stock of the issuer ("Series A Preferred Stock") into shares of common stock of the issuer ("Common Stock"), each share of Series A Preferred Stock automatically converted into 33-1/3 shares of Common Stock, subject to certain limitations, including that a holder of Series A Preferred Stock is prohibited from converting shares of Series Preferred Stock into shares of Common Stock if, as a result of such conversion, such holder, together with its affiliates, would beneficially own more than 19.9% of the total number of shares of Common Stock issued and outstanding immediately after giving effect to such conversion.
F2 Shares are owned directly by Seven One Eight Three Four Irrevocable Trust (the "Trust"). The reporting person is a trustee and beneficiary of the Trust.

Remarks:

Exhibits 24.1 and 24.2 filed herewith.